Vaxsyna, Inc.

Franklin, NH

UEI
EZB7XANUD2A3
CAGE
945G8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
45 Circle Dr, Franklin, NH 03235, USA
Website
vaxsyna.com
Founded
2020
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Vaxsyna, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A plant-made vaccine for the prevention of herpes simplex virus (HSV) Grant · HT94252310708 Defense Health Agency $1,753,267
Low cost, broad spectrum cancer vaccine targeting human papillomavirus - project summary. Human papillomavirus (HPV)… Grant · R41CA271851 National Cancer Institute $1,943,357

Quick answers

What is Vaxsyna, Inc.'s UEI?

Vaxsyna, Inc.'s Unique Entity ID (UEI) in SAM.gov is EZB7XANUD2A3.

What is Vaxsyna, Inc.'s CAGE code?

Vaxsyna, Inc.'s CAGE code is 945G8.

What is Vaxsyna, Inc.'s primary NAICS code?

Vaxsyna, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Vaxsyna, Inc. located?

Vaxsyna, Inc.'s physical address in SAM.gov is 45 Circle Dr, Franklin, NH 03235, USA.

Is Vaxsyna, Inc. registered in SAM.gov?

Yes. Vaxsyna, Inc.'s SAM.gov registration is active through December 3, 2026.

What is Vaxsyna, Inc.'s most recent federal award?

Vaxsyna, Inc.'s most recent federal grant award is A plant-made vaccine for the prevention of herpes simplex virus (HSV) (HT94252310708), from Defense Health Agency, on August 1, 2023.

On GovTribe

See Vaxsyna, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors